Press Releases

Chitosan Market Size is Forecasted to Reach US$ 27.36 Billion by 2030

Share This Article

According to Precedence Research, the global chitosan market size is forecasted to reach US$ 27.36 billion by 2030 from US$ 7 billion in 2021, by growing at a lucrative CAGR of 25% between 2021 and 2030.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.

Chitosan is a sugar derived from the tough outer skeletons of shellfish such as crab, lobster, and shrimp. It is utilized in medicine. Chitosan is used to treat hypertension, high cholesterol, obesity, wound healing, and other ailments, however there is no scientific proof to back up many of its claims. Chitosan is used in pharmaceutical manufacture as filler in tablets, to improve the way certain medications dissolve, and to conceal bitter flavors.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1335

Crucial factors accountable for market growth are:

  • The increasing demand of Chitosan in the end user industries
  • Rising water treatment activities at the global level
  • Significant progress in the healthcare/medical industry in industrialized countries
  • Rising obesity and overweight rates in the region, as well as increased public health awareness

Market Dynamics

Driver

Increasing demand of Chitosan in Cosmetics Industry

Skincare is the fastest expanding segment of the beauty business. In the United States, sales of skincare products increased by 13% last year, while makeup sales increased by only 1%. During that time, online beauty businesses rose by 24 percent, with skincare leading the way. Net-a- The bestselling category in Porter’s beauty department is skincare, which has grown 40 percent year over year. According to L’Oréal, skincare accounts for 40% of the beauty market but accounts for approximately 60% of global cosmetics industry growth. Chitin, chitosan, and its derivatives are widely utilized in cosmetics, owing to their antioxidant, cleaning, protective, humectant, and antioxidant properties. Because of its particular benefits in the cosmetics sector, the increased demand for skincare in the cosmetics market will have a significant impact on the chitosan market.

Restraint

High production cost owing to the irregular supply of the raw material

The irregular supply of raw materials will hamper the chitosan market growth. India’s shrimp exports fell 14 percent year on year to 575,000 MT in 2020, with the United States, China, and the European Union remaining the country’s top clients. Its raw peeled product sales fell 12% to 21,200 MT last year, while its overall exports of cooked and other value-added products to the US grew. Ecuador, which increased sales of raw peeled products by 15,000 MT, compensated for its decrease in output on the worldwide market. Ecuador increased its shipments of mid-sized shrimp to the United States significantly last year, whereas India lost 14 percent of its market share in the United States. India also lost market share in the shell-on market in the United States to Ecuador and Indonesia.Such irregularities in the raw materials supply, the overall value chain may hamper which in turn hamper the chitosan overall production volume.

Opportunities

Increasing obesity and overweight issues in the region and rising health awareness among people

The region’s expanding obesity and overweight issues, as well as people’s growing health consciousness, will generate prospects for the chitosan industry. According to the Institute of Health Metrics and Evaluation, around 30.0 percent of the world’s population is fat or overweight. According to the CDC, roughly 93 million Americans over the age of 20, or nearly 40% of the U.S. population, have excessive cholesterol, putting them at an elevated risk of heart disease and stroke. Western European countries with the highest cholesterol levels in the world, such as Greenland, Iceland, Andorra, and Germany, have mean blood total cholesterol levels of roughly 5.5 mmol/L.Early study suggests that consuming chitosan orally may lower cholesterol, aid to repair anemia, and enhance physical strength, appetite, and sleep in persons on hemodialysis who have renal failure.

Challenges

The imposition of ban on the import/export

One aspect that was not considered in its conclusions, but which is expected to have a substantial impact on world commerce, is a proposed ban on shrimp imports from India by the European Union. This country is the world’s second-biggest producer of farmed shrimp and the largest source of imports to the Netherlands and the United Kingdom. Following ten years of concerns about the presence of antibiotics in shrimp, India’s pre-export control process will be audited in November. During this procedure, all cargoes going for the EU must be scrutinized, and the EU Commission last year boosted its own inspection regime on consignments from India from 10% to 50%.

Despite guarantees from Indian officials, 11 examples of noncompliance, mainly with nitrofurans, have been registered since the beginning of the year. As a result, the EU has reached the end of its patience, and if the upcoming audit uncovers ongoing flaws in the system, a ban is a very real prospect.

Report Highlights

  • Based on the sources, the Chitosan market is dominated by shrimp followed by crab. Shrimp is considered the primary source of chitosan because it contains approximately 25% to 40% chitin, whereas crab shell contains approximately 15% to 20%.
  • The waste water segment is the most prominent segment in the market which contributed largest share in the Chitosan market. Nations have enacted stringent regulations prohibiting the pollution of naturally occurring water bodies and the illegal discharge of wastewater which will create a positive impact on the Chitosan market.

Recent Developments

  • Bioavanta-Bosti, a pioneer in chitosan nanoparticle research, introduced Novochizol in March 2020, a novel chitosan nanoparticle technology that can be utilised to transport and limit any prospective anti-COVID-19 medicine to the lungs of critically ill patients.
  • In March 2021, the University of Brasilia, in collaboration with the University of Campinas, Brazil, Centro de Pesquisa em Biotecnologia Ltda, Hospital Regional da Asa Norte (HRAN), Hospital da Regio Leste (HRL), and Hospital Universitário de Brasilia (HUB/UnB), was conducting the VESTA clinical trial to assess the effectiveness of a novel respirator with chitosan nanoparticles.

Regional Snapshots

The Asia Pacific held the largest share in the Chitosan market. One of the primary elements boosting chitosan demand is the easy availability of its raw material, derived as a waste product from the fishing sector. Vietnam is the Southeast Asian country making inroads in the shrimp industry, increasing its farmed shrimp exports by 8% in 2020 to USD 3.3 billion, aided by an increase in vannamei prawn sales due to increased retail demand during the pandemic. India, the world’s largest shrimp exporter, had a tough year in 2020, with the COVID-19 pandemic significantly affecting production and export performance. Last year, the South Asian country produced between 650,000 and 700,000 metric tons of shrimp, falling from 780,000 to 800,000 MT in 2019. Production in India’s shrimp-farming states of Odisha, West Bengal, Andhra Pradesh, and Gujarat all declined in 2020, according to data from the Society of Aquaculture Professionals (SAP).

Scope of the Chitosan Market Report

Report Highlights Details
Market Size in 2030 USD 27.36 Billion
Growth Rate CAGR of 25% From 2021 to 2030
Largest Market Asia Pacific
Fastest Growing Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Source, Application, Geography

Competitive Intelligence

The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.

Some of the prominent players in the global chitosan market are listed as below:

  • Primex EHF
  • Heppe Medical Chitosan GmbH
  • Vietnam Food
  • KitoZyme S.A.
  • Agratech
  • Advanced Biopolymers AS (Norway)
  • BIO21 Co., Ltd.
  • G.T.C. Bio Corporation
  • Taizhou City Fengrun Biochemical Co., Ltd.
  • Zhejiang Golden-Shell Pharmaceutical Co., Ltd.
  • Biophrame Technologies
  • Heppe Medical Chitosan GmbH
  • Meron Biopolymer
  • Qingdao Yunzhou Biochemistry Co.
  • Golden-Shell Pharmaceutical Co. Ltd
  • FMC Corp.

Segments Covered in the Report

By Source

  • Shrimps
  • Prawns
  • Crabs
  • Other Sources

By Application

  • Water treatment
  • Cosmetics
  • Pharmaceutical and Biomedical
  • Food and Beverage
  • Other Applications

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Chitosan Market 

5.1. COVID-19 Landscape: Chitosan Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Chitosan Market, By Source

8.1. Chitosan Market, by Source Type, 2021-2030

8.1.1. Shrimps

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Prawns

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Crabs

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Other Sources

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Chitosan Market, By Application

9.1. Chitosan Market, by Application, 2021-2030

9.1.1. Water treatment

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Cosmetics

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Pharmaceutical and Biomedical

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Food and Beverage

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Chitosan Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Source (2019-2030)

10.1.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Source (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Source (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Source (2019-2030)

10.2.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Source (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Source (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Source (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Source (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Source (2019-2030)

10.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Source (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Source (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Source (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Source (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Source (2019-2030)

10.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Source (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Source (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Source (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Source (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Source (2019-2030)

10.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Source (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Source (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

Chapter 11. Company Profiles

11.1. Primex EHF

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Heppe Medical Chitosan GmbH

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Vietnam Food

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. KitoZyme S.A.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Agratech

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Advanced Biopolymers AS (Norway)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. BIO21 Co., Ltd.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. G.T.C. Bio Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Taizhou City Fengrun Biochemical Co., Ltd.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Zhejiang Golden-Shell Pharmaceutical Co., Ltd.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global chitosan market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for chitosan are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable. 

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1335

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button